[Federal Register Volume 63, Number 7 (Monday, January 12, 1998)]
[Notices]
[Pages 1869-1870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-652]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC) and 
Subcommittee on Genetic Testing: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meetings.

    Name: Subcommittee on Genetic Testing, Clinical Laboratory 
Improvement Advisory Committee (CLIAC).
    Times and Dates: 8:30 a.m.-4:30 p.m., January 27, 1998; 8:30 
a.m.-4:30 p.m., January 28, 1998.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee advises CLIAC on issues related to 
Genetic Testing.
    Matters To Be Discussed: Agenda items include a discussion on 
the definition of Genetic Testing under the Clinical Laboratory 
Improvement Amendments (CLIA) regulations; and the use of general 
versus specific CLIA requirements for pre-analytic, analytic, and 
post-analytic components of genetic testing.
    Agenda items are subject to change as priorities dictate.

    Name: Clinical Laboratory Improvement Advisory Committee.
    Times and Dates: 8:30 a.m.-4:30 p.m., January 29, 1998; 8 a.m.-
4:30 p.m., January 30, 1998.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, E, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate the technological advances.
    Matters To Be Discussed: Agenda items include an update on CLIA 
implementation; CLIA requirements for the pre-analytic, analytic, 
and post-analytic components of Genetic Testing; International 
Guidelines for Proficiency Testing (PT) programs; and criteria for 
adding analytes to CLIA PT requirements.
    Agenda items are subject to change as priorities dictate.
    Contact Person: John C. Ridderhof, Dr. P.H., Division of 
Laboratory Systems, Public Health Practice Program Office, CDC, 4770 
Buford Highway, NE, M/S G-25, Atlanta, Georgia 30341-3724, telephone 
770/488-4674.


[[Page 1870]]


    Dated: January 5, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 98-652 Filed 1-9-98; 8:45 am]
BILLING CODE 4163-18-P